Increases in rates of 73.0, 48.8, and 36.8 percent seen for children aged 10 to 12 years, 13 to 15 years, and girls
Dengue Travel Alert for the Americas Reissued
The U.S. government once again confirmed dengue is an ongoing risk in many parts of Central and South America, Mexico, and the Caribbean.
On April 17, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced it had reissued a Watch – Level 1, Practice Usual Precautions notice regarding various dengue outbreaks in countries throughout the Americas.
This CDC travel alert was originally posted on August 27, 2019.
Intentional, Suspected Suicidal Cannabis Exposures Increased From 2009 to 2021
However, most cases involved more than one substance
COVID-19 Vaccines Effective Against Moderate, Severe Disease in Children, Teens
Vaccine effectiveness waned significantly after ≥150 days during the omicron variant phase
Amubarvimab Plus Romlusevimab Safe, Effective for COVID-19
Reduces risk for hospitalizations and/or deaths for nonhospitalized patients at high risk for clinical progression
COVID-19 mRNA Booster Authorizations Expanded
The U.S. Food and Drug Administration (FDA) today announced it amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
This action on April 18, 2023, includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) for all doses administered to individuals six months of age and older, including for an additional dose or doses for specific populations.
Oral Fluvoxamine Plus Budesonide Cuts Severe Disease in COVID-19
Reduction in incidence of severe disease requiring advanced care seen among high-risk outpatients with COVID-19
SARS-CoV-2 Infection Linked to Increased Risk for Diabetes
Fraction of incident diabetes cases attributable to SARS-CoV-2 infection was 3.41 percent overall, 4.75 percent among men
FDA Authorizes Spring COVID-19 Booster for Certain Americans
Original mRNA vaccines are being pulled from the market in favor of the bivalent vaccines, which target both the omicron variant and the original strain of COVID-19
UPDATE: Human Infection with Bird Flu in Chile
The U.S. Centers for Disease Control and Prevention (CDC) today published an addendum to Technical Report: Highly Pathogenic Avian Influenza A(H5N1) Viruses, which provides a summary of the case and the genomic analysis of the avian influenza virus from the first H5N1 infection reported in a human in Chile.
Recent tests completed on the Chilean man infected with bird flu indicate that this avian virus has partially adapted to spread between mammals, such as bears, cats, and dogs.